Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Vsee Health (VSEE) EBITDA Margin (2023 - 2025)

Vsee Health (VSEE) has disclosed EBITDA Margin for 3 consecutive years, with 51.69% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EBITDA Margin rose 168616.0% year-over-year to 51.69%, compared with a TTM value of 63.57% through Sep 2025, up 66140.0%, and an annual FY2024 reading of 596.38%, down 56389.0% over the prior year.
  • EBITDA Margin was 51.69% for Q3 2025 at Vsee Health, up from 66.51% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 6.42% in Q1 2024 and bottomed at 1737.85% in Q3 2024.
  • Average EBITDA Margin over 3 years is 197.46%, with a median of 54.25% recorded in 2023.
  • The sharpest move saw EBITDA Margin tumbled -171352bps in 2024, then surged 168616bps in 2025.
  • Year by year, EBITDA Margin stood at 7.74% in 2023, then crashed by -948bps to 81.07% in 2024, then surged by 36bps to 51.69% in 2025.
  • Business Quant data shows EBITDA Margin for VSEE at 51.69% in Q3 2025, 66.51% in Q2 2025, and 55.14% in Q1 2025.